Print Page  |  Close Window

Investor Relations

Investor Relations

STERIS plc is a leading provider of infection prevention and procedural surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical device companies. Our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.

NYSE   |   STE (common stock)
$89.19 + 1.62
Stock chart for: STE.  Currently trading at $89.19 with a 52 week high of $93.39 and a 52 week low of $65.27.
12/15/17 4:06 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent Press Releases

STERIS to Participate in the J.P. Morgan Healthcare Conference

Read More

STERIS Announces Financial Results for Fiscal 2018 Second Quarter

Read More

STERIS to Announce Fiscal 2018 Second Quarter Financial Results on November 1, 2017

Read More

Investor Events

Monday, January 8, 2018 
3:30 p.m. PT
STERIS plc at the J.P. Morgan Healthcare Conference
Wednesday, November 1, 2017 
10:00 a.m. ET
Q2 2018 STERIS plc Earnings Conference Call